Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank62
5Y CAGR-10.1%
Studio
Year-over-Year Change

Year-over-year book value per share growth

5Y CAGR
-10.1%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202538.74%
2024-36.12%
2023674.99%
2022-63.17%
2021-69.33%
202066.14%
2019-69.81%
2018-50.94%
2017166.85%
2016-35.23%